Skip to main content

Ultra Simple Brugada Criteria


VT vs SVT with Aberrancy – ECG Criteria for Accurate Diagnosis

Wide complex tachycardia (WCT) is VT unless proven otherwise. Correct differentiation between ventricular tachycardia (VT) and supraventricular tachycardia (SVT) with aberrancy is critical because management differs significantly and misdiagnosis can be dangerous.



---


1. Basic Definitions


Ventricular Tachycardia (VT)


A tachycardia originating below the His bundle (ventricular myocardium or Purkinje system), usually with wide QRS ≥ 120 ms.


SVT with Aberrancy


A supraventricular rhythm conducted through abnormal ventricular conduction (e.g., bundle branch block or accessory pathway), producing a wide QRS.



---


2. Why It Matters


Treating VT as SVT (e.g., giving AV nodal blockers in unstable VT) can cause hemodynamic collapse.


Treating SVT as VT is generally safer (e.g., amiodarone).


In structural heart disease, ischemic heart disease, or prior MI → assume VT.




---


Stepwise ECG Approach to Wide Complex Tachycardia



---


Step 1: Clinical Clues


Suggests VT:


Age > 35 years


Structural heart disease


Previous MI


Cardiomyopathy


History of ventricular arrhythmia



Suggests SVT:


Known SVT history


Young patient without structural disease




---


Step 2: AV Dissociation (Most Specific Sign of VT)


Findings:


P waves independent of QRS


Capture beats


Fusion beats



If AV dissociation present → VT until proven otherwise



---


Step 3: QRS Duration


QRS ≥ 140 ms (RBBB morphology) → favors VT


QRS ≥ 160 ms (LBBB morphology) → favors VT


Very wide QRS (> 180 ms) → strongly VT




---


Step 4: Concordance in Chest Leads


Definition: All precordial leads either entirely positive or entirely negative


Positive concordance → VT


Negative concordance → VT



Concordance is highly specific for VT.



---


Step 5: Brugada Criteria


Developed by Pedro Brugada.


Four-step algorithm:


1. Absence of RS complex in all precordial leads → VT



2. RS interval > 100 ms in any precordial lead → VT



3. AV dissociation present → VT



4. Morphologic criteria for VT in V1–V2 and V6




If any step positive → VT



---


Step 6: Vereckei (aVR) Algorithm


Developed by LΓ‘szlΓ³ Vereckei.


Focuses mainly on lead aVR:


Initial R wave in aVR → VT


Initial r or q > 40 ms in aVR → VT


Notching on downstroke of QRS in aVR → VT


Vi/Vt ratio ≤ 1 → VT



Useful when bundle branch morphology is unclear.



---


Step 7: Morphologic Criteria


If RBBB Pattern in V1


Suggests VT if:


Monophasic R


qR pattern


Broad R (> 40 ms)


R/S ratio < 1 in V6



Suggests SVT if:


rSR' typical pattern


Narrow initial r wave



If LBBB Pattern in V1


Suggests VT if:


Broad initial R in V1


Notched S in V1


Q wave in V6



Suggests SVT if:


Typical LBBB morphology


Narrow initial r wave




---


Comparative Table


Feature VT SVT with Aberrancy


AV dissociation Present Absent

Capture/Fusion beats Present Absent

QRS width Very wide Moderately wide

Concordance Often present Rare

Structural heart disease Common Less common

Response to adenosine No termination May terminate




---


Special Situations


1. Pre-excited SVT (WPW with AF)


Irregular wide tachycardia

Very fast ventricular rate

Avoid AV nodal blockers


2. Fascicular VT


Relatively narrow QRS

RBBB morphology

Responds to verapamil



---


Practical Emergency Rule


If unsure → treat as VT


Unstable → immediate synchronized cardioversion


Stable → amiodarone or procainamide



Avoid verapamil in undifferentiated WCT (risk of collapse in VT).



---


Key Take-Home Points


AV dissociation is the most specific ECG sign of VT.


Concordance strongly favors VT.


Use Brugada or Vereckei algorithm systematically.


Wide complex tachycardia in structural heart disease = VT until proven otherwise.


When in doubt, manage as VT.


Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.